Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

New TECFIDERA® (dimethyl fumarate) data show sustained efficacy and long-term safety in a broad range of multiple sclerosis patients
Daclizumab in multiple sclerosis: a high-yield extension study.
Specific inhibition of secreted NRG1 types I-II by heparin enhances Schwann Cell myelination.
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA TM*) in Multiple Sclerosis
Predictors of Fatigue Impact in Persons With Long-Standing Multiple Sclerosis.
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.
Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.
A silver lining of neuroinflammation: Beneficial effects on myelination.
Geography in multiple sclerosis.
Microglia across the lifespan: from origin to function in brain development, plasticity and cognition.
Beta-Interferon, Glatiramer Acetate Cost-Effective in MS
Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
Optical Coherence Tomography in Multiple Sclerosis.
Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
Differences in the burden of psychiatric comorbidity in MS vs the general population.
10 years of interferon beta-1b (Beta feron therapy.
Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process.
Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients.
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.

Pages